vTv Therapeutics (VTVT) Asset Utilization Ratio (2015 - 2026)
vTv Therapeutics' (VTVT) quarterly Asset Utilization Ratio came in at 0.4 in Q2 2026, up 67878.14% year-over-year from N/an in Q2 2025, and up 1.24% quarter-over-quarter from 0.39 in Q1 2026.
Analysis
vTv Therapeutics (VTVT) Asset Utilization Ratio (2015 - 2026) Analysis & Trends
vTv Therapeutics has disclosed Asset Utilization Ratio across 12 years of filings, most recently posting 0.4 for Q2 2026.
- In Q2 2026, Asset Utilization Ratio rose 67878.14% year-over-year to 0.4; the TTM figure through Jun 2026 stood at 0.4 (up 67878.14% YoY), while the FY2024 annual figure was 0.04, changed N/A from the prior year.
- Asset Utilization Ratio came in at 0.4 for Q2 2026 at vTv Therapeutics, up from 0.39 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.4 in Q2 2026 to a low of 0.0 in Q3 2025.
- Average Asset Utilization Ratio over 5 years is 0.09, with a median of 0.02 recorded in 2024.
- Year-over-year, Asset Utilization Ratio sank 99.8% in 2023 and surged 80618.2% in 2026.
- Over 5 years, Asset Utilization Ratio stood at 0.06 in 2022, then slumped by 99.18% to 0.0 in 2023, then soared by 5083.04% to 0.02 in 2024, then tumbled by 98.92% to 0.0 in 2025, then surged by 146309.62% to 0.4 in 2026.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.4 in Q2 2026, 0.39 in Q1 2026, and 0.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 0.57 |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 0.31 |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 0.36 |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 0.69 |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 0.77 |
| 10 | vTv Therapeutics | 413.85 Mn | 413.85 Mn | - | 0.40 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.40 |
| Mar 31, 2026 | 0.39 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | 0.02 |
| Mar 31, 2024 | 0.03 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.06 |
| Sep 30, 2022 | 0.06 |
| Jun 30, 2022 | 0.18 |
| Mar 31, 2022 | 0.22 |
| Dec 31, 2021 | 0.14 |
| Sep 30, 2021 | 0.39 |
| Jun 30, 2021 | 0.39 |
| Mar 31, 2021 | 0.47 |